Avanti Polar Lipids: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:Avanti Polar Lipids logo.PNG|right|225px]] | [[Image:Avanti Polar Lipids logo.PNG|right|225px]] | ||
'''Avanti Polar Lipids, Inc.''' is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in [[ | '''Avanti Polar Lipids, Inc.''' is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in [[1967]] by [[Walt Shaw]] and is located at 700 [[Industrial Park Drive]] in [[Alabaster]]. The company's best-known achievement is the development of "Exosurf", a surfactant used in the treatment of infant respiratory distress syndrome, common in premature births. | ||
The company constructed a new 14,000 square-foot office for its analytical services division in [[2011]]. In [[2020]] Avanti was acquired by Croda International of Snaith, United Kingdom. | The company constructed a new 14,000 square-foot office for its analytical services division in [[2011]]. In [[2020]] Avanti was acquired by Croda International of Snaith, United Kingdom. | ||
In [[2021]] Avanti undertook a $26 million expansion of its Alabaster facility. | |||
{{stub}} | {{stub}} | ||
Line 8: | Line 10: | ||
* Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." {{BBJ}} | * Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." {{BBJ}} | ||
* Patchen, Tyler (July 9, 2020) "European company acquires local biotech firm." {{BBJ}} | * Patchen, Tyler (July 9, 2020) "European company acquires local biotech firm." {{BBJ}} | ||
* Van der Bijl, Hanno (April 9, 2021) "Avanti Polar Lipids expanding campus in Shelby County." {{BBJ}} | |||
==External links== | ==External links== | ||
* [http://www.avantilipids.com/ Avanti Polar Lipids] website | * [http://www.avantilipids.com/ Avanti Polar Lipids] website | ||
[[Category: | [[Category:1967 establishments]] | ||
[[Category:Industrial Park Drive]] | [[Category:Industrial Park Drive]] | ||
[[Category: | [[Category:Biotechnology]] |
Latest revision as of 16:54, 12 April 2021
Avanti Polar Lipids, Inc. is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in 1967 by Walt Shaw and is located at 700 Industrial Park Drive in Alabaster. The company's best-known achievement is the development of "Exosurf", a surfactant used in the treatment of infant respiratory distress syndrome, common in premature births.
The company constructed a new 14,000 square-foot office for its analytical services division in 2011. In 2020 Avanti was acquired by Croda International of Snaith, United Kingdom.
In 2021 Avanti undertook a $26 million expansion of its Alabaster facility.
References
- Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." Birmingham Business Journal
- Patchen, Tyler (July 9, 2020) "European company acquires local biotech firm." Birmingham Business Journal
- Van der Bijl, Hanno (April 9, 2021) "Avanti Polar Lipids expanding campus in Shelby County." Birmingham Business Journal
External links
- Avanti Polar Lipids website